We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden.
- Authors
Thunander, Maria; Törn, Carina; Petersson, Christer; Ossiansson, Birger; Fornander, Jan; Landin-Olsson, Mona
- Abstract
Objective: C-peptide is a main outcome measure in treatment trials of diabetes. C-peptide also has a role in the classification of diabetes, which is often difficult in adults and this is also increasingly recognised in adolescents and elders. Aim: We aimed to describe the levels of C-peptide in relation to age and body mass index (BMI) in a large population-based cohort of adults with newly diagnosed diabetes and compare the capabilities of C-peptide, age and BMI to discriminate between autoimmune and non-autoimmune diabetes. Subjects and methods: Blood samples from 1180 patients were analysed regarding islet cell antibody, glutamic acid decarboxylase antibody and fasting C-peptide (FCP). Receiver operating characteristics (ROC) curves were analysed to check the ability of age, BMI and C-peptide to discriminate between autoantibody-positive (Ab+) and -negative (Ab-) diabetes. Results: Mean FCP was 0.73±0.5 (range 0.13-1.80) nmol/l in the Ab+ and 1.42±0.9 (range 0.13-8.30) nmol/l in the Ab-. FCP was 0.02 nmol/l higher per year increase in age at diagnosis of diabetes. Mean BMI was 26.0G4.8 (range 18.0-39.0) kg/m2 in the Ab- and 28.9±5.3 (range 15.5-62.6) kg/m2 in the AbK. FCP increased with age also within each BMI group. The highest area under the curve (AUC) in the ROC analysis was found for C-peptide, followed by age and BMI (0.78, 0.68 and 0.66 respectively). Conclusions: At diagnosis of diabetes, C-peptide was superior to age and BMI in discriminating between autoimmune and non-autoimmune diabetes. C-peptide increased significantly with BMI and age, latter also within each BMI group. Most of the adults had normal or high levels of C-peptide at presentation of diabetes among the autoimmune patients.
- Subjects
SWEDEN; C-peptide; BODY mass index; DIABETES; AUTOIMMUNITY; HEALTH outcome assessment; GLUTAMATE decarboxylase
- Publication
European Journal of Endocrinology, 2012, Vol 166, Issue 6, p1021
- ISSN
0804-4643
- Publication type
Article
- DOI
10.1530/EJE-11-0797